271 related articles for article (PubMed ID: 33130246)
1. Transplantation of telomerase/myocardin-co-expressing mesenchymal cells in the mouse promotes myocardial revascularization and tissue repair.
Madonna R; Pieragostino D; Rossi C; Guarnieri S; Nagy CT; Giricz Z; Ferdinandy P; Del Boccio P; Mariggiò MA; Geng YJ; De Caterina R
Vascul Pharmacol; 2020 Dec; 135():106807. PubMed ID: 33130246
[TBL] [Abstract][Full Text] [Related]
2. Telomerase/myocardin expressing mesenchymal cells induce survival and cardiovascular markers in cardiac stromal cells undergoing ischaemia/reperfusion.
Madonna R; Guarnieri S; Kovácsházi C; Görbe A; Giricz Z; Geng YJ; Mariggiò MA; Ferdinandy P; De Caterina R
J Cell Mol Med; 2021 Jun; 25(12):5381-5390. PubMed ID: 33949765
[TBL] [Abstract][Full Text] [Related]
3. Transplantation of mesenchymal cells rejuvenated by the overexpression of telomerase and myocardin promotes revascularization and tissue repair in a murine model of hindlimb ischemia.
Madonna R; Taylor DA; Geng YJ; De Caterina R; Shelat H; Perin EC; Willerson JT
Circ Res; 2013 Sep; 113(7):902-14. PubMed ID: 23780385
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of the secretome of adipose tissue-derived murine mesenchymal cells overexpressing telomerase and myocardin.
Madonna R; Angelucci S; Di Giuseppe F; Doria V; Giricz Z; Görbe A; Ferdinandy P; De Caterina R
J Mol Cell Cardiol; 2019 Jun; 131():171-186. PubMed ID: 31055035
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of inositol hexakisphosphate kinases (IP6Ks) enhances mesenchymal stem cell engraftment and improves therapeutic efficacy for myocardial infarction.
Zhang Z; Liang D; Gao X; Zhao C; Qin X; Xu Y; Su T; Sun D; Li W; Wang H; Liu B; Cao F
Basic Res Cardiol; 2014 Jul; 109(4):417. PubMed ID: 24847908
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells overexpressing MiR-126 enhance ischemic angiogenesis via the AKT/ERK-related pathway.
Chen JJ; Zhou SH
Cardiol J; 2011; 18(6):675-81. PubMed ID: 22113756
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart.
Dakhlallah D; Zhang J; Yu L; Marsh CB; Angelos MG; Khan M
J Cardiovasc Pharmacol; 2015 Mar; 65(3):241-51. PubMed ID: 25658461
[TBL] [Abstract][Full Text] [Related]
8. Genetic modification of mesenchymal stem cells overexpressing CCR1 increases cell viability, migration, engraftment, and capillary density in the injured myocardium.
Huang J; Zhang Z; Guo J; Ni A; Deb A; Zhang L; Mirotsou M; Pratt RE; Dzau VJ
Circ Res; 2010 Jun; 106(11):1753-62. PubMed ID: 20378860
[TBL] [Abstract][Full Text] [Related]
9. Epac-Rap1-activated mesenchymal stem cells improve cardiac function in rat model of myocardial infarction.
Khan I; Ali A; Akhter MA; Naeem N; Chotani MA; Iqbal H; Kabir N; Atiq M; Salim A
Cardiovasc Ther; 2017 Apr; 35(2):. PubMed ID: 28039940
[TBL] [Abstract][Full Text] [Related]
10. Myocardin a enhances telomerase activities in adipose tissue mesenchymal cells and embryonic stem cells undergoing cardiovascular myogenic differentiation.
Madonna R; Willerson JT; Geng YJ
Stem Cells; 2008 Jan; 26(1):202-11. PubMed ID: 17916802
[TBL] [Abstract][Full Text] [Related]
11. Myocardin-A enhances expression of promyogenic genes without depressing telomerase activity in adipose tissue-derived mesenchymal stem cells.
Madonna R; Wu D; Wassler M; De Caterina R; Willerson JT; Geng YJ
Int J Cardiol; 2013 Sep; 167(6):2912-21. PubMed ID: 22884695
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction.
Chen Y; Zhao Y; Chen W; Xie L; Zhao ZA; Yang J; Chen Y; Lei W; Shen Z
Stem Cell Res Ther; 2017 Nov; 8(1):268. PubMed ID: 29178928
[TBL] [Abstract][Full Text] [Related]
13. Transplantation of adipose tissue mesenchymal cells conjugated with VEGF-releasing microcarriers promotes repair in murine myocardial infarction.
Madonna R; Petrov L; Teberino MA; Manzoli L; Karam JP; Renna FV; Ferdinandy P; Montero-Menei CN; Ylä-Herttuala S; De Caterina R
Cardiovasc Res; 2015 Oct; 108(1):39-49. PubMed ID: 26187727
[TBL] [Abstract][Full Text] [Related]
14. Intracoronary Administration of Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction.
Bobi J; Solanes N; Fernández-Jiménez R; Galán-Arriola C; Dantas AP; Fernández-Friera L; Gálvez-Montón C; Rigol-Monzó E; Agüero J; Ramírez J; Roqué M; Bayés-Genís A; Sánchez-González J; García-Álvarez A; Sabaté M; Roura S; Ibáñez B; Rigol M
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28468789
[TBL] [Abstract][Full Text] [Related]
15. Combined intramyocardial delivery of human pericytes and cardiac stem cells additively improves the healing of mouse infarcted hearts through stimulation of vascular and muscular repair.
Avolio E; Meloni M; Spencer HL; Riu F; Katare R; Mangialardi G; Oikawa A; Rodriguez-Arabaolaza I; Dang Z; Mitchell K; Reni C; Alvino VV; Rowlinson J; Livi U; Cesselli D; Angelini G; Emanueli C; Beltrami AP; Madeddu P
Circ Res; 2015 May; 116(10):e81-94. PubMed ID: 25801898
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction.
Grauss RW; Winter EM; van Tuyn J; Pijnappels DA; Steijn RV; Hogers B; van der Geest RJ; de Vries AA; Steendijk P; van der Laarse A; Gittenberger-de Groot AC; Schalij MJ; Atsma DE
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2438-47. PubMed ID: 17644573
[TBL] [Abstract][Full Text] [Related]
17. Small extracellular vesicles obtained from hypoxic mesenchymal stromal cells have unique characteristics that promote cerebral angiogenesis, brain remodeling and neurological recovery after focal cerebral ischemia in mice.
Gregorius J; Wang C; Stambouli O; Hussner T; Qi Y; Tertel T; Börger V; Mohamud Yusuf A; Hagemann N; Yin D; Dittrich R; Mouloud Y; Mairinger FD; Magraoui FE; Popa-Wagner A; Kleinschnitz C; Doeppner TR; Gunzer M; Meyer HE; Giebel B; Hermann DM
Basic Res Cardiol; 2021 Jun; 116(1):40. PubMed ID: 34105014
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
[TBL] [Abstract][Full Text] [Related]
19. Human Umbilical Cord-Derived Mesenchymal Stromal Cells Improve Left Ventricular Function, Perfusion, and Remodeling in a Porcine Model of Chronic Myocardial Ischemia.
Liu CB; Huang H; Sun P; Ma SZ; Liu AH; Xue J; Fu JH; Liang YQ; Liu B; Wu DY; Lü SH; Zhang XZ
Stem Cells Transl Med; 2016 Aug; 5(8):1004-13. PubMed ID: 27334487
[TBL] [Abstract][Full Text] [Related]
20. Wharton's jelly-derived mesenchymal stem cells promote myocardial regeneration and cardiac repair after miniswine acute myocardial infarction.
Zhang W; Liu XC; Yang L; Zhu DL; Zhang YD; Chen Y; Zhang HY
Coron Artery Dis; 2013 Nov; 24(7):549-58. PubMed ID: 23892469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
